Pharmacological characterization of losartan as a CCR2 antagonist and pre-clinical and pharmacodynamic assessment as a potential anti-metastatic therapy
Date
2017
Authors
Regan, Daniel P., author
Dow, Steven, advisor
Schenkel, Alan, committee member
Thamm, Douglas, committee member
Slansky, Jill, committee member
Basaraba, Randall, committee member
Journal Title
Journal ISSN
Volume Title
Abstract
To view the abstract, please see the full text of the document.
Description
Rights Access
Subject
CCL2
dogs
monocytes
CCR2
cancer
metastasis